101 – 110 of 118
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)
- Contribution to journal › Article
-
Mark
Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid
- Contribution to journal › Article
- 2016
-
Mark
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease
- Contribution to journal › Article
-
Mark
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
- Contribution to journal › Article
- 2015
-
Mark
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
- Contribution to journal › Article
- 2013
-
Mark
Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment
- Contribution to journal › Article
- 2012
-
Mark
Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI
- Contribution to journal › Article
- 2011
-
Mark
Multidimensional Treatment Foster Care (MTFC): Results from an independent replication
- Contribution to journal › Article
- 2010
-
Mark
No Association of VEGF Polymorphims with Alzheimer's Disease
- Contribution to journal › Article
